E-Cigarettes, the FDA, Public Health, and Harm Reduction: A Response to the Open Peer Commentaries
Abstract
We appreciate that all our commentators accepted the central framework we argued for, namely that the FDA has multiple roles and attendant responsibilities, and we are excited to see this framework...Author Profiles
Other Versions
No versions found
(no proxy)My notes
Similar books and articles
Harm Reduction Ethics, Public Health, and the Manufacture of Doubt.Daniel S. Goldberg -2022 -American Journal of Bioethics 22 (10):18-20.
E-Cigarettes and the Multiple Responsibilities of the FDA.Larisa Svirsky,Dana Howard &Micah L. Berman -2021 -American Journal of Bioethics 22 (10):5-14.
E-Cigarette Use and Regulation: A Comparative Analysis between the United States, the UK, and China.Fengmin Shao,Yue Gu,Lijun Shen,Yuming Wang &Hui Zhang -2022 -American Journal of Bioethics 22 (10):29-31.
Stepping Up or Stepping Back: FDA Roles in Producing and Shaping Knowledge of Pediatric Covid-19 Vaccines.Sophia Bessias &Elizabeth Lanphier -2022 -American Journal of Bioethics 22 (10):26-28.
Limitations on the Capability of the FDA to Advise.Aaron S. Kesselheim &Leah Z. Rand -2022 -American Journal of Bioethics 22 (10):15-17.
Moral Wrongs, Epistemic Wrongs, and the FDA.Jack Harris -2022 -American Journal of Bioethics 22 (10):34-37.
Expanded FDA regulation of health and wellness apps.T. J. Kasperbauer &David E. Wright -2019 -Bioethics 34 (3):235-241.
Response to Open Peer Commentaries on “Ethical Responsibilities for Companies That Process Personal Data”.Matthew S. McCoy,Ezekiel J. Emanuel &Steven Joffe -2024 -American Journal of Bioethics 24 (3):1-5.
Health and Social Justice: Which Inequalities Matter ? Response to Open Peer Commentaries on “The Social Determinants of Health: Why Should We Care?”.Adina Preda &Kristin Voigt -2015 -American Journal of Bioethics 15 (8):1-3.
Response to Open Peer Commentaries for “There’s No Harm in Talking: Reestablishing the Relationship Between Theological and Secular Bioethics”.Michael McCarthy,Mary Homan &Michael Rozier -2021 -American Journal of Bioethics 21 (1):W1-W3.
Analytics
Added to PP
2022-10-27
Downloads
39 (#642,199)
6 months
12 (#292,601)
2022-10-27
Downloads
39 (#642,199)
6 months
12 (#292,601)
Historical graph of downloads
How can I increase my downloads?Author Profiles
References found in this work
Advice on Vaping in the Face of Empirical and Ethical Uncertainty.Kalle Grill -2022 -American Journal of Bioethics 22 (10):20-22.
Harm Reduction Ethics, Public Health, and the Manufacture of Doubt.Daniel S. Goldberg -2022 -American Journal of Bioethics 22 (10):18-20.
Moral Wrongs, Epistemic Wrongs, and the FDA.Jack Harris -2022 -American Journal of Bioethics 22 (10):34-37.
E-Cigarettes, the FDA’s Strategic Orientation, and Lessons from the Opioid Crisis.Jake Monaghan &Brandon del Pozo -2022 -American Journal of Bioethics 22 (10):23-25.
External Dynamics Contextualizing the FDA’s Role in E-Cigarette Regulation.Omar Gaidarov &Rachel Asher -2022 -American Journal of Bioethics 22 (10):32-34.
Home |New books and articles |Bibliographies |Philosophy journals |About PhilPapers |API |Contact us |Code of conduct
PhilPapers logo byAndrea Andrews andMeghan Driscoll.
This site uses cookies and Google Analytics (see ourterms & conditions for details regarding the privacy implications).Use of this site is subject toterms & conditions.
All rights reserved byThe PhilPapers Foundation
Server: philpapers-web-54b44b69b7-sq5lk uwo